Atlas Trials

Assess the Effectiveness of Atomoxetine in Children With Fetal Alcohol Syndrome and ADD/ADHD

Clinical trial NCT00417794 · COMPLETED

Trial details

NCT number
NCT00417794
Sponsor
University of Oklahoma
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Fetal Alcohol SyndromeAttention Deficit Disorder With Hyperactivity (ADHD)Attention Deficit Disorder (ADD)
Start date
2005-08-01
Primary completion
2015-04-22
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.